Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M CONDON

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
ACS Medicinal Chemistry Letters|July 16, 2025
Discovery of VNRX-9945, a Potent, Broadly Active Capsid Assembly Modulator as a Clinical Candidate for the Treatment of Chronic Hepatitis B Virus InfectionBin Liu, Jiangchao Yao, Thomas Haimowitz, et al.
Cell|November 21, 2007
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosisJames E Vince, W Wei-Lynn Wong, Nufail Khan, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2006
Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4Christopher Blackburn, Bing Guan, James Brown, et al.
Cell Death and Differentiation|January 21, 2017
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathwaysMaria C Tanzer, Nufail Khan, James A Rickard, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Journal of Personality|September 26, 2020
The distinction between symptoms and traits in the Hierarchical Taxonomy of Psychopathology (HiTOP)Colin G DeYoung, Michael Chmielewski, Lee Anna Clark, et al.
Science Translational Medicine|May 20, 2016
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemiaGabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Molecular Cancer Therapeutics|February 25, 2014
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft modelsChristopher A Benetatos, Yasuhiro Mitsuuchi, Jennifer M Burns, et al.
Personality Science|April 18, 2022
Why Has Personality Psychology Played an Outsized Role in the Credibility Revolution?Olivia E Atherton, Joanne M Chung, Kelci Harris, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
ACS Medicinal Chemistry Letters|July 16, 2025
Discovery of VNRX-9945, a Potent, Broadly Active Capsid Assembly Modulator as a Clinical Candidate for the Treatment of Chronic Hepatitis B Virus InfectionBin Liu, Jiangchao Yao, Thomas Haimowitz, et al.
Cell|November 21, 2007
IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosisJames E Vince, W Wei-Lynn Wong, Nufail Khan, et al.
Bioorganic & Medicinal Chemistry Letters|April 29, 2006
Identification and characterization of 4-aryl-3,4-dihydropyrimidin-2(1H)-ones as inhibitors of the fatty acid transporter FATP4Christopher Blackburn, Bing Guan, James Brown, et al.
Cell Death and Differentiation|January 21, 2017
Combination of IAP antagonist and IFNγ activates novel caspase-10- and RIPK1-dependent cell death pathwaysMaria C Tanzer, Nufail Khan, James A Rickard, et al.
Nature Communications|February 19, 2015
RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKLKate E Lawlor, Nufail Khan, Alison Mildenhall, et al.
Journal of Personality|September 26, 2020
The distinction between symptoms and traits in the Hierarchical Taxonomy of Psychopathology (HiTOP)Colin G DeYoung, Michael Chmielewski, Lee Anna Clark, et al.
Science Translational Medicine|May 20, 2016
The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemiaGabriela Brumatti, Chunyan Ma, Najoua Lalaoui, et al.
Molecular Cancer Therapeutics|February 25, 2014
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft modelsChristopher A Benetatos, Yasuhiro Mitsuuchi, Jennifer M Burns, et al.
Personality Science|April 18, 2022
Why Has Personality Psychology Played an Outsized Role in the Credibility Revolution?Olivia E Atherton, Joanne M Chung, Kelci Harris, et al.
Journal of Medicinal Chemistry|April 2, 2014
Birinapant, a smac-mimetic with improved tolerability for the treatment of solid tumors and hematological malignanciesStephen M Condon, Yasuhiro Mitsuuchi, Yijun Deng, et al.
Pageof 17